Buscar

01/05/2025 Managing diabetes across female reproductive stages
Mauricio, D, Gratacòs, M, Franch-Nadal, J. Managing diabetes across female reproductive stages. TRENDS IN ENDOCRINOLOGY AND METABOLISM. 2025; 36(5)DOI:10.1016/j.tem.2025.02.003. PMID:40089417. IF:12.600(Q1/1D).
09/04/2025 Preeclampsia as an independent predictor of atherosclerosis progression in women with type 1 diabetes: a 5-year prospective study
Mesa, A, Puig-Jove, C, Pané, A, Vinagre, I, López-Quesada, E, Meler, E, Alonso-Carril, N, Quirós, C, Amor, AJ, Perea, V. Preeclampsia as an independent predictor of atherosclerosis progression in women with type 1 diabetes: a 5-year prospective study. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02719-3. PMID:40205402. IF:10.600(Q1/1D).
02/04/2025 Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes
Barranco-Altirriba, M, Rossell, J, Alonso, N, Weber, RJM, Ortega, E, Lloyd, GR, Hernandez, M, Yanes, O, Capellades, J, Winder, C, Junza, A, Falguera, M, Franch-Nadal, J, Dunn, WB, Perera-Lluna, A, Castelblanco, E, Mauricio, D. Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02701-z. PMID:40176064. IF:10.600(Q1/1D).
01/04/2025 Transitioning between automated insulin delivery systems: A focus on personalisation
Beato-Víbora, PI, Chico, A, Moreno-Fernandez, J, Azriel-Mira, S, Nattero-Chávez, L, Mora, RV, Alonso-Carril, N, Simó-Servat, O, Aguilera-Hurtado, E, Céspedes, LMR, de Adana, MR, Domínguez, M, Márquez-Pardo, R, Díaz-Soto, G, Martínez-Brocca, MA, Fernández, KA, Buesa, MA, Hernández, MC, Quirós, C. Transitioning between automated insulin delivery systems: A focus on personalisation. DIABETES RESEARCH AND CLINICAL PRACTICE. 2025; 222DOI:10.1016/j.diabres.2025.112070. PMID:40020785. IF:7.400(Q1/1D).
01/04/2025 Clinical characteristics and management of type 2 diabetes in primary care in Spain. SED2 Study
Antonio-Arques, V, Camins, BF, Vlacho, B, Barrot, J, Pérez, JN, Torre, EM, Mauricio, D, Franch-Nadal, J. Clinical characteristics and management of type 2 diabetes in primary care in Spain. SED2 Study. Endocrinologia Diabetes y Nutricion. 2025; 72(4)DOI:10.1016/j.endien.2025.501543. PMID:40180835. IF:1.800(Q3/8D).
01/03/2025 Can a mobile application improve glucose-related and patient-reported outcome measures (PROMs) in people with type 1 diabetes mellitus? A randomized controlled trial using the mySugr® app
Cuixart, G, Corcoy, R, González, C. Can a mobile application improve glucose-related and patient-reported outcome measures (PROMs) in people with type 1 diabetes mellitus? A randomized controlled trial using the mySugr® app. Hormones-International Journal of Endocrinology and Metabolism. 2025; 24(1)DOI:10.1007/s42000-024-00609-z. PMID:39412732. IF:2.500(Q3/7D).
21/02/2025 Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study
Amigó, N, Castelblanco, E, Julve, J, Martínez-Micaelo, N, Alonso, N, Hernández, M, Ribalta, J, Guardiola, M, Torán-Monserrat, P, Lopez-Lifante, V, Herrero-Alonso, C, Arteaga, I, Ortega, E, Franch-Nadal, J, Mauricio, D. Advanced serum lipoprotein and glycoprotein profiling for cardiovascular event prediction in type 2 diabetes mellitus: the LIPOCAT study. Cardiovascular Diabetology. 2025; 24(1)DOI:10.1186/s12933-025-02636-5. PMID:39985069. IF:10.600(Q1/1D).
01/02/2025 Centenarians-the way to healthy vascular ageing and longevity: a review from VascAgeNet
Summer, S, Borrell-Pages, M, Bruno, RM, Climie, RE, Dipla, K, Dogan, A, Eruslanova, K, Fraenkel, E, Mattace-Raso, F, Pugh, CJA, Rochfort, KD, Ross, M, Roth, L, Schmidt-Trucksaess, A, Schwarz, D, Shadiow, J, Sohrabi, Y, Sonnenberg, J, Tura-Ceide, O, Tuna, BG, Julve, J, Dogan, S. Centenarians-the way to healthy vascular ageing and longevity: a review from VascAgeNet. GeroScience. 2025; 47(1)DOI:10.1007/s11357-024-01467-8. PMID:39725804. IF:5.400(Q1/1D).